Algo version: 0.98b
GuiZhou SanLi is listed at the SHH Exchange
GuiZhou SanLi [603439.SS]
SHH Sector: Healthcare Industry:Biotechnology

Is GuiZhou SanLi stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, GuiZhou SanLi pays dividends. Last time was Monday 17th of June 2024 where the investors holding the stock on Monday 17th of June 2024 were paid CNY0.2 per share. Over the last 3 times between 2021 and 2024, GuiZhou SanLi has paid CNY0.55 with an average of CNY0.18 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for GuiZhou SanLi 10 years ago, but if you had invested on Tuesday 28th of April 2020 when the price was CNY10.58, you would have made a profit of CNY3.13 per share or 29.58%

Yes, the average daily trading liquidity for GuiZhou SanLi is CNY9.61 million. You should therefore be able to get in and out of your positions relatively fast.

GuiZhou SanLi has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a normal cash flow to debt ratio of 0.33, the company's ability to pay off the debt is normal. GuiZhou SanLi has a good net profit margin of 16.19% and should have high tolerances against inflation.

We have calculated the inflation risk for GuiZhou SanLi to be low [0.4 of 1]

US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.09 and is down -0.37 over the last 30 days.